Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
RFK Jr looks to alter rare disease regulation by fast-tracking drug approvals
During an FDA panel discussion, the US health secretary prioritised easier routes to market for curative therapies.
Ozempic linked to rare cases of serious eye disorder
Novo Nordisk's popular weight-loss and diabetes drugs Wegovy and Ozempic may, in very rare cases, cause a serious eye condition that can lead to vision loss, the European Medicines Agency's sa...
AstraZeneca’s Calquence approved by EC for first-line chronic lymphocytic leukaemia use
An estimated 27,000 cases of the disease were diagnosed in the UK, France, Germany, Spain and Italy in 2024
Dyne Therapeutics to Present New Preclinical Data
Dyne Therapeutics to Present New Preclinical Data in Facioscapulohumeral Muscular Dystrophy at the FSHD Society International Research Congress
Radiopharm Theranostics Reports Preclinical
Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake
Darolutamide Receives FDA Approval for mCSPC
The FDA approved darolutamide monotherapy for use in metastatic hormone-sensitive prostate cancer following ARANOTE findings.
Four States Ask F.D.A. to Lift Special Restrictions on Abortion Pill
The states consider it a move to force the F.D.A. to review and acknowledge extensive research showing the pill’s safety. Mifepristone, which blocks a hormone necessary for pregnancy to develop, was...
FDA phasing out animal testing in preclinical safety studies
The Food and Drug Administration (FDA) said it will reduce or replace its animal testing requirement for “more effective, human-relevant methods,” such as artificial intelligence (AI&#...
Alvotech and Advanz to commercialise biosimilars in Europe
Alvotech and UK-based Advanz Pharma have broadened their commercial collaboration with an agreement to include three additional biosimilar candidates for commercialisation in Europe.
UCLA Study Finds SSRIs Enhance T Cell Activity and Reduce Tumor Growth in Preclinical Cancer Models
A recent study conducted by researchers at UCLA has identified a potential link between commonly used antidepressants and enhanced cancer-fighting capabilities of the immune system.
Silexion Therapeutics announces preclinical results on SIL204
Silexion Therapeutics (SLXN) announced compelling preclinical data demonstrating the efficacy of its next-generation RNAi therapeutic candidate, SIL204, against human pancreatic, colorectal an...
Sevabertinib Given FDA Priority Review for HER2+ NSCLC
The oral TKI sevabertinib has been granted priority review for use in patients harboring HER2 mutations in non-small cell lung cancer. The FDA gave sevabertinib breakthrough therapy designation for HE...
41
42
43
44
45
46
47
48
49
